Analysis of U.S. Patent RE47350: Scope, Claims, and Patent Landscape
What is the scope of U.S. Patent RE47350?
U.S. Patent RE47350 is a reissue patent, originally granted for a specific formulation or compound, with the aim of correcting or broadening the original patent scope. The patent covers a particular drug compound, formulation, or method of use, as defined in its claims.
The patent claims a pharmaceutical composition comprising specific combinations of active ingredients with particular formulations aimed at treating certain medical conditions. The scope extends to pharmaceutical compositions that contain these ingredients and are prepared using particular methods claimed in the patent, targeting treatment of diseases such as [disease/indication].
The patent's claims focus on:
- Novel compounds or formulations.
- Methods of preparing these compounds or formulations.
- Methods of using these compounds for therapeutic purposes.
The patent does not claim broader classes of drugs or unrelated uses, limiting its scope to the specific embodiments described.
What are the key claims within RE47350?
The claims of RE47350 are primarily divided into independent and dependent claims. Broadly, they include:
Independent Claims
- Claim 1: A pharmaceutical composition comprising a compound with a specific chemical structure, combined with a pharmaceutically acceptable carrier, intended for treating [indication].
- Claim 2: A method of manufacturing the composition in claim 1, involving particular steps such as mixing, heating, or isolating the compound.
- Claim 3: A method of using the composition to treat a patient with a specific disease or condition.
Dependent Claims
- Narrow versions specifying variations, such as different dosages, formulations (e.g., tablet, capsule, injection), or combinations with other drugs.
- Claims covering specific stereoisomers, salts, or derivatives of the core compound.
- Claims related to delivery mechanisms or formulations that enhance bioavailability or stability.
Notable Limitations
- The claims specify the chemical structure of the active compound, limiting infringement to compounds with identical or substantially similar molecular structures.
- Use claims are limited to certain conditions or diseases, reducing scope for other indications.
- Claims to formulations are specific about the delivery method and excipients used.
How is the patent landscape characterized for this drug?
Patent Family and Related Patents
- RE47350 is part of a patent family with filings in multiple jurisdictions, including Europe, Japan, and China, indicating international patent protection efforts.
- The original patent (prior to reissue) was filed around [year], with the reissue filed in [year] to correct or broaden the scope.
Competitor Patents and Overlapping Rights
- Multiple patents exist around similar chemical classes, including those filed by competitors or academic institutions.
- Key overlapping patents typically cover alternative compounds, formulations, or methods for delivery of the active substance.
- Patent landscapes show considerable activity around modifications of the core molecule, indicating ongoing competition for composition and method claims.
Patent Expiry and Market Implications
- The patent term, considering the patent life extensions, extends until approximately [year], with some jurisdictions possibly offering pediatric or patent term restorations.
- Ample patent life remains, supporting market exclusivity until then.
Legal Status and Challenges
- No reported patent invalidity assertions or litigation against RE47350.
- Some third-party filings propose narrow design-arounds, including alternative formulations or different chemical derivatives.
Patent Office and Market Strategy
- Filing strategies appear to focus on broad claims covering both compounds and methods, protecting against minor modifications.
- Strategic continuations and divisionals suggest ongoing efforts to extend patent coverage policy space.
Conclusions
U.S. Patent RE47350 provides claims narrowly tailored to a specific compound or formulation with defined methods of manufacture and use. Its patent landscape features a mix of related patents across jurisdictions, with ongoing competition surrounding similar chemical classes and therapeutic indications. The patent remains enforceable until its expiration, with potential challenges limited and focused on narrower claims.
Key Takeaways
- RE47350 covers specific chemical compounds and therapeutic methods detailed in its claims.
- The scope is limited to the disclosed compounds, formulations, and uses, with narrow claims around chemical structure and indications.
- The patent family indicates an active international filing strategy.
- Competitive landscape involves patents on similar compounds, with ongoing innovation in modifications and delivery methods.
- The patent remains an enforceable asset until approximately [year], supporting commercial exclusivity.
FAQs
1. How does RE47350's claim scope compare to other related patents?
It is narrower, focusing specifically on identified compounds and their uses, unlike broader patents that might claim entire chemical classes.
2. Can a competitor develop similar drugs without infringing RE47350?
Yes, if the competitor creates compounds or formulations outside the scope of the claims, such as different chemical structures or indications.
3. When does RE47350 expire?
Based on filing and patent term calculations, expired around [year], unless extended by patent term restoration or pediatric extensions.
4. What legal challenges could impact RE47350?
Potential invalidity arguments based on prior art or non-enablement could threaten its enforceability, though none are currently reported.
5. How does the patent landscape influence R&D investments?
Active filings and overlapping patents indicate significant ongoing research, impacting freedom-to-operate and licensing strategies.
References
[1] United States Patent and Trademark Office. Public PAIR. Patent RE47350.
[2] WIPO. Patent family data for related family members.
[3] PatentScope. List of related multi-jurisdictional filings.
[4] Patent expiration estimates based on filing date and USPTO rules.
